Amputation Risk in Type II Diabetes Mellitus Patients Treated with SGLT-2 Inhibitors: A Systematic Literature Review of Randomized Clinical Trials.
使用 SGLT-2 抑制劑治療的 II 型糖尿病患者截肢風險:隨機臨床試驗的系統文獻回顧。
Drug Res (Stuttg) 2024-08-02
Cardiovascular Effectiveness and Safety of Antidiabetic Drugs in Patients with Type 2 Diabetes and Peripheral Artery Disease: Systematic Review.
2 型糖尿病及周邊動脈疾病患者抗糖尿病藥物的心血管療效與安全性:系統性回顧。
Medicina (Kaunas) 2024-09-28
Impact of SGLT2 inhibitors on lower limb complications: a mendelian randomization perspective.
SGLT2 抑制劑對下肢併發症的影響:一項孟德爾隨機化的觀點。
Front Pharmacol 2024-10-02
The Potential Impact of SGLT2-I in Diabetic Foot Prevention: Promising Pathophysiologic Implications, State of the Art, and Future Perspectives-A Narrative Review.
SGLT2-I 在糖尿病足預防中的潛在影響:有前景的病理生理意涵、最新進展及未來展望 - 敘述性綜述。
Medicina (Kaunas) 2024-11-27
Efficacy and Safety of SGLT-2 Inhibitors in Patients With and Without Advanced CKD: A Systematic Review and Meta-Analysis.
SGLT-2 抑制劑在有無晚期 CKD 患者中的療效與安全性:系統性回顧與統合分析。
Clin J Am Soc Nephrol 2025-03-26
Effects of SGLT2 Inhibitors on Cardiovascular and Lower Limb Events in Patients with Type 2 Diabetes: A Nationwide Population-Based Study.
SGLT2 抑制劑對於 2 型糖尿病患者心血管及下肢事件的影響:一項全國性人口基礎研究。
Diabetes Metab Syndr Obes 2025-04-02
Insightful Perspectives on Sodium-glucose Co-transporter 2 Inhibitors: Navigating Safety Updates and Beyond.
鈉-葡萄糖共轉運蛋白 2 抑制劑的深刻見解:安全性更新及其後續探討。
Curr Drug Res Rev 2025-04-04
Comparison of New-Onset Peripheral Artery Disease in Patients With Type 2 Diabetes Exposed to Sodium-Glucose Cotransporter-2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, or Glucagon-Like Peptide-1 Agonists: A Population-Based Cohort Study.
第二型糖尿病患者使用SGLT2抑制劑、DPP-4抑制劑或GLP-1受體促效劑後新發周邊動脈疾病的比較:一項以人口為基礎的世代研究
J Am Heart Assoc 2025-05-22